Literature DB >> 23448543

Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: a metabolomic approach.

Anabel García-Heredia1, Elizabeth Kensicki, Robert P Mohney, Anna Rull, Iris Triguero, Judit Marsillach, Carmen Tormos, Bharti Mackness, Michael Mackness, Diana M Shih, Juan Pedro-Botet, Jorge Joven, Guillermo Sáez, Jordi Camps.   

Abstract

Oxidative stress is a determinant of liver steatosis and the progression to more severe forms of disease. The present study investigated the effect of paraoxonase-1 (PON1) deficiency on histological alterations and hepatic metabolism in mice fed a high-fat high-cholesterol diet. We performed nontargeted metabolomics on liver tissues from 8 male PON1-deficient mice and 8 wild-type animals fed a high-fat, high-cholesterol diet for 22 weeks. We also measured 8-oxo-20-deoxyguanosine, reduced and oxidized glutathione, malondialdehyde, 8-isoprostanes and protein carbonyl concentrations. Results indicated lipid droplets in 14.5% of the hepatocytes of wild-type mice and in 83.3% of the PON1-deficient animals (P < 0.001). The metabolomic assay included 322 biochemical compounds, 169 of which were significantly decreased and 16 increased in PON1-deficient mice. There were significant increases in lipid peroxide concentrations and oxidative stress markers. We also found decreased glycolysis and the Krebs cycle. The urea cycle was decreased, and the pyrimidine cycle had a significant increase in orotate. The pathways of triglyceride and phospholipid synthesis were significantly increased. We conclude that PON1 deficiency is associated with oxidative stress and metabolic alterations leading to steatosis in the livers of mice receiving a high-fat high-cholesterol diet.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448543     DOI: 10.1021/pr400050u

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  19 in total

Review 1.  Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors.

Authors:  Jordi Camps; Jorge Joven
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

2.  Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease.

Authors:  E Rodríguez-Gallego; M Guirro; M Riera-Borrull; A Hernández-Aguilera; R Mariné-Casadó; S Fernández-Arroyo; R Beltrán-Debón; F Sabench; M Hernández; D del Castillo; J A Menendez; J Camps; R Ras; L Arola; J Joven
Journal:  Int J Obes (Lond)       Date:  2014-03-28       Impact factor: 5.095

3.  Açaí (Euterpe oleracea Martius) supplementation in the diet during gestation and lactation attenuates liver steatosis in dams and protects offspring.

Authors:  Priscila O Barbosa; Melina O de Souza; Deuziane P D Paiva; Marcelo E Silva; Wanderson G Lima; Giovanna Bermano; Renata N Freitas
Journal:  Eur J Nutr       Date:  2019-07-05       Impact factor: 5.614

4.  Exploring the Process of Energy Generation in Pathophysiology by Targeted Metabolomics: Performance of a Simple and Quantitative Method.

Authors:  Marta Riera-Borrull; Esther Rodríguez-Gallego; Anna Hernández-Aguilera; Fedra Luciano; Rosa Ras; Elisabet Cuyàs; Jordi Camps; Antonio Segura-Carretero; Javier A Menendez; Jorge Joven; Salvador Fernández-Arroyo
Journal:  J Am Soc Mass Spectrom       Date:  2015-09-17       Impact factor: 3.109

5.  Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol.

Authors:  Eline H van den Berg; Eke G Gruppen; Richard W James; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Lipid Res       Date:  2018-11-19       Impact factor: 5.922

Review 6.  Inflammation, infection, cancer and all that…the role of paraoxonases.

Authors:  Asokan Devarajan; Diana Shih; Srinivasa T Reddy
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 7.  Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

Authors:  Joost Willebrords; Isabel Veloso Alves Pereira; Michaël Maes; Sara Crespo Yanguas; Isabelle Colle; Bert Van Den Bossche; Tereza Cristina Da Silva; Cláudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Alves; Bruno Cogliati; Mathieu Vinken
Journal:  Prog Lipid Res       Date:  2015-06-11       Impact factor: 16.195

8.  A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.

Authors:  Christopher M Depner; Maret G Traber; Gerd Bobe; Elizabeth Kensicki; Kurt M Bohren; Ginger Milne; Donald B Jump
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

9.  Açai (Euterpe oleracea Mart.) Upregulates Paraoxonase 1 Gene Expression and Activity with Concomitant Reduction of Hepatic Steatosis in High-Fat Diet-Fed Rats.

Authors:  Renata Rebeca Pereira; Isabel Cristina Mallosto Emerich de Abreu; Joyce Ferreira da Costa Guerra; Nara Nunes Lage; Juliana Márcia Macedo Lopes; Maísa Silva; Wanderson Geraldo de Lima; Marcelo Eustáquio Silva; Maria Lucia Pedrosa
Journal:  Oxid Med Cell Longev       Date:  2016-08-25       Impact factor: 6.543

10.  A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.

Authors:  Bhavin Parekh
Journal:  F1000Res       Date:  2015-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.